/
BJDX
$1.05+$0.01 (+0.95%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.1M
1M shares
52-week range
$0.83 – $16.68
1% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Change$-170238.94
Bluejay Diagnostics, Inc. Common Stock
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
www.bluejaydx.com- Employees
- 6
- IPO / List date
- Nov 10, 2021
- HQ
- ACTON, MA
Held by traders on TradeandTell
No one on the platform currently holds BJDX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BJDX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-01-29 | 1-for-4reverse |
| 2024-11-18 | 1-for-50reverse |
| 2024-06-20 | 1-for-8reverse |
| 2023-07-24 | 1-for-20reverse |
Recent trades on TradeandTell
No one on the platform has traded BJDX yet.
